These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 29634656)
1. Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study. Abouzaki NA; Christopher S; Trankle C; Van Tassell BW; Carbone S; Mauro AG; Buckley L; Toldo S; Abbate A J Cardiovasc Pharmacol; 2018 Jun; 71(6):375-379. PubMed ID: 29634656 [TBL] [Abstract][Full Text] [Related]
2. Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study). Abbate A; Van Tassell BW; Christopher S; Abouzaki NA; Sonnino C; Oddi C; Carbone S; Melchior RD; Gambill ML; Roberts CS; Kontos MC; Peberdy MA; Toldo S; Vetrovec GW; Biondi-Zoccai G; Dinarello CA Am J Cardiol; 2015 Jan; 115(1):8-12. PubMed ID: 25456867 [TBL] [Abstract][Full Text] [Related]
3. Remote Ischemic Postconditioning (RIPC) of the Upper Arm Results in Protection from Cardiac Ischemia-Reperfusion Injury Following Primary Percutaneous Coronary Intervention (PCI) for Acute ST-Segment Elevation Myocardial Infarction (STEMI). Cao B; Wang H; Zhang C; Xia M; Yang X Med Sci Monit; 2018 Feb; 24():1017-1026. PubMed ID: 29456238 [TBL] [Abstract][Full Text] [Related]
4. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966 [TBL] [Abstract][Full Text] [Related]
5. A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction. Mauro AG; Mezzaroma E; Marchetti C; Narayan P; Del Buono MG; Capuano M; Prestamburgo A; Catapano S; Salloum FN; Abbate A; Toldo S J Cardiovasc Pharmacol; 2017 May; 69(5):273-278. PubMed ID: 28195949 [TBL] [Abstract][Full Text] [Related]
6. Magnesium lithospermate B reduces myocardial ischemia/reperfusion injury in rats via regulating the inflammation response. Quan W; Wei G; Zhou D; Zhu Y; Guo C; Wang Y; Weng Y; Xi M; Wen A Pharm Biol; 2013 Nov; 51(11):1355-62. PubMed ID: 23863120 [TBL] [Abstract][Full Text] [Related]
7. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). Daaboul Y; Korjian S; Weaver WD; Kloner RA; Giugliano RP; Carr J; Neal BJ; Chi G; Cochet M; Goodell L; Michalak N; Rusowicz-Orazem L; Alkathery T; Allaham H; Routray S; Szlosek D; Jain P; Gibson CM Am J Cardiol; 2016 Sep; 118(5):625-31. PubMed ID: 27392509 [TBL] [Abstract][Full Text] [Related]
8. Low-Level Tragus Stimulation for the Treatment of Ischemia and Reperfusion Injury in Patients With ST-Segment Elevation Myocardial Infarction: A Proof-of-Concept Study. Yu L; Huang B; Po SS; Tan T; Wang M; Zhou L; Meng G; Yuan S; Zhou X; Li X; Wang Z; Wang S; Jiang H JACC Cardiovasc Interv; 2017 Aug; 10(15):1511-1520. PubMed ID: 28797427 [TBL] [Abstract][Full Text] [Related]
9. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction. Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956 [TBL] [Abstract][Full Text] [Related]
10. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction. Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551 [TBL] [Abstract][Full Text] [Related]
11. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality. Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Mandurino-Mirizzi A; Crimi G; Raineri C; Pica S; Ruffinazzi M; Gianni U; Repetto A; Ferlini M; Marinoni B; Leonardi S; De Servi S; Oltrona Visconti L; De Ferrari GM; Ferrario M J Cardiovasc Med (Hagerstown); 2018 May; 19(5):240-246. PubMed ID: 29470249 [TBL] [Abstract][Full Text] [Related]
13. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial. Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244 [TBL] [Abstract][Full Text] [Related]
15. The effects of remote ischemic conditioning in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a meta-analysis. Gao J; Chen Q; Liu F; Zhao Q; Chen B; Zhou Y; Zhao Q; Ma Y; Yang Y Minerva Med; 2017 Aug; 108(4):370-380. PubMed ID: 28217986 [TBL] [Abstract][Full Text] [Related]
16. Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury. Kohlhauer M; Dawkins S; Costa ASH; Lee R; Young T; Pell VR; Choudhury RP; Banning AP; Kharbanda RK; ; Saeb-Parsy K; Murphy MP; Frezza C; Krieg T; Channon KM J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29626151 [TBL] [Abstract][Full Text] [Related]
17. Adverse interaction between HDL and the mass of myocardial infarction. Soares AAS; Carvalho LSF; Bonilha I; Virginio VW; Nadruz Junior W; Coelho-Filho OR; Quinaglia E Silva JC; Petrucci Junior O; Sposito AC; Atherosclerosis; 2019 Feb; 281():9-16. PubMed ID: 30583243 [TBL] [Abstract][Full Text] [Related]
18. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794 [TBL] [Abstract][Full Text] [Related]
19. Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial. Le Corvoisier P; Gallet R; Lesault PF; Audureau E; Paul M; Ternacle J; Ghostine S; Champagne S; Arrouasse R; Bitari D; Mouillet G; Dubois-Randé JL; Berdeaux A; Ghaleh B; Deux JF; Teiger E BMC Cardiovasc Disord; 2018 Oct; 18(1):193. PubMed ID: 30340532 [TBL] [Abstract][Full Text] [Related]
20. Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center. Nozari Y; Eshraghi A; Talasaz AH; Bahremand M; Salamzadeh J; Salarifar M; Pourhosseini H; Jalali A; Mortazavi SH Am J Cardiovasc Drugs; 2018 Jun; 18(3):213-221. PubMed ID: 29322434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]